Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blemaren for coral urate nephrolithiasis
NCT07162974Completed
- Sponsor
- Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
- Start
- Jan 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Blemaren in nephrolithiasis, sponsored by Moscow State University of Medicine and Dentistry named after A.I. Evdokimov. Primary endpoint: Assessment of the size, volume and density of stones at 1 month. Started Jan 2023; status: completed.
02
Drugs
Blemaren
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT07162974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07162974.